ArticleThe Journal of pharmacology and experimental therapeutics2014

A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.

Clinton E Canal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.